- Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
- Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
- Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
- Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Key statistics
On Thursday, Accelerate Diagnostics Inc (AXDX:NAQ) closed at 0.9163, 25.52% above the 52 week low of 0.73 set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.9288 |
---|---|
High | 0.93 |
Low | 0.86 |
Bid | 0.8403 |
Offer | 0.9621 |
Previous close | 0.905 |
Average volume | 37.32k |
---|---|
Shares outstanding | 21.66m |
Free float | 13.62m |
P/E (TTM) | -- |
Market cap | 18.85m USD |
EPS (TTM) | -5.51 USD |
Data delayed at least 15 minutes, as of May 16 2024 20:59 BST.
More ▼